Log in to save to my catalogue

Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric spec...

Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric spec...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8a0abc545ac346ba9dc7517cc43c701f

Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays

About this item

Full title

Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays

Publisher

England: BioMed Central

Journal title

Molecular neurodegeneration, 2023-04, Vol.18 (1), p.20-20, Article 20

Language

English

Formats

Publication information

Publisher

England: BioMed Central

More information

Scope and Contents

Contents

Aggregation of α-synuclein (α-syn) is a prominent feature of Parkinson's disease (PD) and other synucleinopathies. Currently, α-syn seed amplification assays (SAAs) using cerebrospinal fluid (CSF) represent the most promising diagnostic tools for synucleinopathies. However, CSF itself contains several compounds that can modulate the aggregation of...

Alternative Titles

Full title

Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8a0abc545ac346ba9dc7517cc43c701f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8a0abc545ac346ba9dc7517cc43c701f

Other Identifiers

ISSN

1750-1326

E-ISSN

1750-1326

DOI

10.1186/s13024-023-00613-8

How to access this item